AME

Business profile & competitive position

AMETEK, Inc. sits in the Industrials sector, specifically the Electrical Equipment & Parts industry. The company is organized around two operating groups: Electronic Instruments (EIG) and Electromechanical (EMG). EIG designs and manufactures advanced analytical, test and measurement instruments for the process, aerospace, power and industrial markets. EMG supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects, primarily to aerospace and defense, medical, automation and other industrial markets.

The numbers frame AMETEK as a collection of niche technology franchises rather than a commodity parts supplier. In 2025, sales reached $7,401.1 million, up 6.6% from 2024, while diluted EPS rose 7.9% to $6.40. The company also posted record operating income, net income, orders and backlog. A net margin of 20.0% is unusually strong for a diversified industrial components company, which points to pricing power and engineered differentiation. ROE of 14.5% is comfortably above most cost-of-capital thresholds and supports the idea that management deploys capital productively, especially given its steady acquisition activity. At the same time, the current $54.9 billion market cap and P/E of 34.9 suggest the market already prices in these competitive strengths.

Financial posture

AMETEK carries a $54.9 billion market capitalization and trades at a P/E of 34.9. That multiple sits at a clear premium to typical industrial multiples, so the valuation implicitly requires continued above-average earnings growth and margin stability. The 20.0% net margin provides a profitability cushion that is uncommon in the Electrical Equipment & Parts space, while the 14.5% ROE confirms the company is converting earnings into shareholder returns. With a beta of 1.00, the stock has historically moved roughly in line with the broader market.

At the recent snapshot, the shares are at $239.55, slightly below the 50-day EMA of $241.73, and the RSI is 41.9, a neutral level that neither reads overbought nor oversold. A P/E of 34.9 is easiest to reconcile if AMETEK keeps delivering the double-digit EPS growth it targets under its own growth model. The first crack in that premium would likely show up as pressure on the 20.0% net margin, since that margin is what separates AMETEK from lower-margin, more cyclical industrial peers.

Strategic priorities & outlook

AMETEK’s most recent 10-K outlines a repeatable growth model built around high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. Operationally, it supports this through Operational Excellence initiatives that include lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence.

Acquisitions are the second engine. Between 2021 and December 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone, it spent $933.2 million in cash, net of cash acquired, to buy Kern, which provides high-precision machining and optical inspection solutions, and FARO Technologies, a 3D measurement and imaging solutions company. Geographic expansion is also deliberate, with best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia to stay close to customers. International revenue is material: in 2025, 52% of EIG net sales and 42% of EMG net sales went to customers outside the United States. As of December 31, 2025, AMETEK employed approximately 22,500 people.

Macro & geopolitical exposure

As an Electrical Equipment & Parts company with global manufacturing and sales, AMETEK is exposed to the standard macro and geopolitical currents that shape industrial technology suppliers. These include trade policy and tariffs, currency translation effects, supply-chain disruptions, and input cost volatility for metals, semiconductors and other electronic components. The industry’s capital-goods character also means demand tends to track industrial production, aerospace build rates, defense budgets, medical capital spending and automation capex cycles.

Because AMETEK maintains major manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia, and because more than half of EIG sales are outside the United States, the company is inherently sensitive to U.S.-China trade dynamics, regional logistics costs and cross-border regulatory changes. Its aerospace and defense exposure ties a portion of revenue to government procurement and defense budget trajectories, while its medical components business faces healthcare regulation and hospital capital expenditure cycles. Currency swings can further affect reported earnings given the company’s large international revenue base.

Recent developments

Recent headlines from Zacks have highlighted AMETEK’s quality characteristics. On August 21, 2026, Zacks published “Ametek (AME) Upgraded to Buy: Here’s Why” and also included the stock in “5 High ROE Stocks to Buy as Markets Sway on Intense Volatility.” Earlier, on August 10, 2026, Zacks listed AMETEK among “Top 3D Printing Stocks to Buy for Strong Long-Term Potential” and featured it in “Are You Looking for a Top Momentum Pick? Why Ametek (AME) is a Great Choice.” The 3D-printing inclusion likely reflects the FARO Technologies 3D measurement and imaging acquisition more than a core 3D-printing manufacturing operation. The momentum and high-ROE themes line up with the 20.0% net margin and 14.5% ROE the company reports.

Earnings behavior & post-earnings drift

AMETEK has beaten earnings estimates in all of the last eight reported quarters, a 100% beat rate, with an average earnings surprise of 4%. Despite that consistency, the average five-day price move after earnings across those quarters is just 0.46%, classified as “flat.” That pattern suggests the headline beat is rarely a surprise; positive results appear to be largely embedded in the stock by the time the release hits.

The last four quarters illustrate the dynamic. On August 4, 2026, AMETEK reported EPS of $2.09 against an estimate of $1.99, a 5% surprise; the stock rose 0.28% the next day and 0.89% over the following five days. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the shares fell 2.13% the next day and 0.33% over five days. The February 3, 2026 quarter brought $2.01 actual versus $1.94 estimated, a 3.6% surprise, with a next-day drop of 0.48% and a five-day gain of 1.83%. The October 30, 2025 quarter had the largest surprise, 7.4% ($1.89 vs. $1.76), producing a 1.91% next-day pop but a five-day decline of 0.54%. The unofficial consensus may therefore be running ahead of the published estimate. The next scheduled report is October 29, 2026, before the market open, with a consensus EPS estimate of $2.10.

For a deeper dive into how institutional analysts are interpreting AMETEK’s valuation, acquisition strategy and upcoming October 2026 earnings setup, readers should review the full institutional verdict on the ticker.